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Strengths and limitations of this study
 ► Unlike previous studies on child and youth multimor-
bidity, this is a prospective study that uses a mul-
tilevel, multimethod and multi- informant approach.
 ► Multimorbidity in Children and Youth Across the Life- 
course aims to determine biological and psychoso-
cial processes by which some children and youth 
develop multimorbidity whereas others do not; this 
is essential for establishing effective interventions.
 ► Findings have the potential to support children/youth 
and families, improve care and reduce health sys-
tem costs.
 ► Recruitment from a single paediatric tertiary care 
centre might reduce generalisability of findings.
 ► As with all prospective studies, missing data and 
attrition may be problematic; however, multiple ap-
proaches will be used to minimise sample loss and 
other biases.
AbStrACt
Introduction Multimorbidity, the co- occurrence of a 
chronic physical condition and mental disorder, affects a 
substantial number of children and youth and can lead 
to compromised quality of life, hardship for families, and 
an increased burden on the healthcare system. We are 
conducting a study to document the course of mental 
disorder in children and youth diagnosed with a chronic 
physical condition; identify predictors of child and youth 
multimorbidity; examine whether the effects of these 
predictors are moderated by relevant psychosocial and 
biological factors; explore potential inflammatory and 
stress biomarkers that mediate the onset of child and 
youth multimorbidity; and, assess whether multimorbidity 
in children and youth alters patterns of mental health 
service use.
Methods and analysis Multimorbidity in Children and 
Youth Across the Life- course (MY LIFE) is a prospective 
study. Two hundred and fifty children and youth aged 
2–16 years diagnosed with a chronic physical condition 
along with one parent will be recruited from the outpatient 
clinics at a paediatric tertiary care centre. Data will be 
collected using a multi- informant, multimethod design 
at four time- points (at recruitment, and at 6, 12 and 24 
months postrecruitment). Parents will provide reports 
for all children/youth. In addition, youth ≥10 years will 
self- report. Mental disorder will be assessed using 
structured interviews. On completion of data collection, 
participant- reported data will be linked to provincial health 
records to identify mental health services use. Multilevel 
analyses (survival, proportional hazard, structural equation 
modelling) will be used to address MY LIFE objectives.
Ethics and dissemination This study has been approved 
by the University of Waterloo Human Research Ethics 
Board and the Hamilton Integrated Research Ethics Board. 
Findings will be disseminated to key stakeholders using 
a number of outlets (peer- reviewed publications and 
conferences, lay informational pamphlets, social media).
IntroduCtIon
Children and youth with chronic physical 
conditions face considerable psychosocial 
and emotional burden due to their health 
challenges.1 Thus far, research that compre-
hensively examines child and youth multi-
morbidity—the co- occurrence of physical 
and mental disorder—is limited, including 
research on the mechanisms involved in the 
onset and outcomes of multimorbidity.
Yet, understanding child and youth multi-
morbidity is an urgent public health problem. 
Improvements in healthcare have reduced 
childhood mortality, but many surviving chil-
dren grow up into adulthood.2 Furthermore, 
because most adult mental disorders have 
their onset in childhood or adolescence,3 the 
onset of multimorbidity likely typically occurs 
early in life, with long- term consequences 
for children and youth, their families, the 
healthcare system and society. Indeed, cost 
calculations suggest that a small proportion 
of children (approximately 5%, often multi-
morbid) account for nearly 60% of healthcare 
costs for individuals <18 years of age.4 Taken 
together, multimorbidity and its sequelae are 
an important public health concern.5 6
Current research on child and youth multi-
morbidity suggests that its prevalence is 
high.7 Population- based studies report prev-
alence estimates of 20%–30%,8–10 clinical 
studies ≥50%.11 12 Most extant studies report 
that multimorbidity has a negative impact on 
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the quality of life of young people11 13–15 (for an excep-
tion see Ferro et al.16 Impact on the family environment 
appears more mixed, with some studies reporting closer 
parent–child relationships in those with (vs without) 
multimorbidity.16 17 Studies on family sociodemographic 
correlates of multimorbidity are rare, with one study 
reporting no association.11 Emerging evidence implicates 
biological mechanisms that link physical and mental 
disorder, including immunological, inflammatory and 
stress- related mechanisms.18–20 Findings regarding mental 
health services use among children and youth with multi-
morbidity are also mixed; clinical studies reporting less 
use of acute mental health services, whereas population 
studies reporting more overall and acute mental health 
services use.16 21 Despite this nascent literature on child 
and youth multimorbidity, many important gaps in knowl-
edge remain. The Multimorbidity in Children and Youth 
Across the Life- course (MY LIFE) study was developed to 
address these gaps.
First, studies of clinical samples of children and youth 
with physical conditions are typically small and cross- 
sectional.11 22 23 The lack of prospective studies limits 
our ability to: (1) understand the temporality of effects; 
(2) document the natural course of multimorbidity over 
time; (3) calculate incidence rates; (4) generalise find-
ings to the broader population of children and youth 
with multimorbidity. MY LIFE will recruit a larger sample 
of children and youth with a variety of physical condi-
tions and follow them and their families prospectively on 
multiple measurement occasions. This will inform oppor-
tunities for prevention/intervention at all levels: primary 
(preventing onset of mental comorbidity), secondary 
(reducing symptoms in children and youth with subclin-
ical symptomatology) and tertiary (improving function in 
children and youth with multimorbidity). With regards 
to generalisability, few studies (all using population 
samples) have compared mental disorder across physical 
conditions.8 24 25 While findings typically show negligible 
differences across conditions,26 27 identifying condition- 
specific associations may be useful in understanding 
mechanisms underlying the onset of multimorbidity and 
informing intervention.
Second, previous studies have typically assessed symp-
toms of emotional or behavioural problems and not 
mental disorder, per se.12 27 28 This is relevant given recent 
evidence that assessment type moderates estimates of asso-
ciation between physical conditions and mental disorder 
and influences estimates of prevalence in child and youth 
populations.7 29 Furthermore, there is robust evidence 
that agreement on measures of mental and psychoso-
cial health between parent and child/youth reports are 
low.11 30 31 Combined, these methodological limitations 
can bias estimates (via misclassification), which ulti-
mately could misdirect resources for appropriate mental 
healthcare for children and youth. MY LIFE will imple-
ment a multimethod and multi- informant approach to 
measuring child and youth mental health and related 
psychosocial outcomes.
Third, little is known about the mechanisms that 
underlie the development of multimorbidity in chil-
dren and youth. There has been some work highlighting 
biological18 19 and psychosocial mechanisms32 33 inde-
pendently, but few investigations have sought to combine 
these approaches to provide a more comprehensive 
understanding of this phenomenon. One study has 
demonstrated that maternal depression has direct effects 
on immunological and stress regulation in mothers and 
their children, which subsequently influences symptoms 
of mental disorder in children.20 However, that study did 
not examine these mechanisms in the context of chil-
dren having a physical condition. Recent evidence in 
this vulnerable population not only shows a confluence 
of biological and psychosocial pathways linking physical 
and mental health,34 35 but that effects may be different 
for male and female children.36 Relatedly, there is robust 
evidence demonstrating the positive effect of physical 
activity and exercise on the mental health of,37–41 as well 
as reducing levels of inflammatory markers in, children 
and youth.42–44 MY LIFE will measure physical activity and 
inflammatory and stress markers not previously assessed 
in studies of child and youth multimorbidity in an effort 
to more fully understand its onset and progression. Clar-
ifying the extent to which biomarkers and psychoso-
cial factors, and ultimately physical and mental health, 
change over time can inform targets for intervention to 
reduce risk for multimorbidity.
Fourth, use of mental healthcare has increased dramat-
ically for children and youth in recent years,45 but knowl-
edge as to whether multimorbidity influences service 
use or help- seeking behaviour is limited. The few studies 
that exist have reported inconsistent findings: a popula-
tion study found increased mental healthcare use among 
youth with a physical condition and bipolar disorder,21 
whereas a clinical study found that youth with multi-
morbidity were less likely to receive inpatient mental 
healthcare and had shorter hospital stays.16 Through 
data linkage activities with administrative health records, 
MY LIFE will contribute to the field by identifying how 
children and youth with multimorbidity access and use 
mental health services. Understanding the patterns of 
mental healthcare for children and youth with multimor-
bidity will provide useful information to support families 
navigating the health system and the evidence required 
to implement models of integrated physical and mental 
healthcare.
Overall, MY LIFE aims to: (1) document the course of 
mental disorder in children and youth diagnosed with 
a chronic physical condition; (2) identify predictors of 
child and youth multimorbidity; (3) examine whether 
the effects of these predictors are amplified or moder-
ated by relevant psychosocial and biological factors; (4) 
explore potential inflammatory and stress biomarkers 
that mediate the onset of child and youth multimor-
bidity; (5) assess the extent to which child and youth 
multimorbidity alters patterns of mental health service 
use.
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Figure 1 Multimorbidity in Children and Youth Across the Life- course study flowchart. KBIT-2, Kaufman Brief Intelligence Test, 
second edition; MINI- KID, Mini International Neuropsychiatric Interview for Children and Adolescents; RA, research assistant; 
ROI, release of information.
MEthodS
design 
The design of MY LIFE was informed by our pilot study.11 
MY LIFE is a prospective study in which children and 
youth with chronic physical conditions and their primary 
caregiving parent/guardian will be recruited from outpa-
tient programmes at a paediatric hospital in Canada. 
Participants will be followed for 24 months, with assess-
ments at four occasions: recruitment (baseline) and 
6, 12 and 24 months. On completion of the in- person 
data collection, participant- reported data will be linked 
to provincial health records to document use of mental 
health services.
Participants
Children and youth aged 2–16 years with one chronic 
physical condition is the population of interest. Physician- 
diagnosed physical conditions are those expected to last 
≥12 months; and result in ≥1 of the following sequelae—
functional limitations, dependencies to compensate for 
limitations and need for additional healthcare.46
Children and youth with multiple physical conditions 
(ie, medically complex) at the time of recruitment will 
be excluded as these children/youth represent a small 
subgroup within this population and whose outcomes 
and healthcare use are established.47–49 Associations with 
mental comorbidity in these children and youth is likely 
different compared with children and youth who suffer 
from one, physical condition only. Also, children/youth 
and parents with insufficient English language skills will 
be excluded, because the selected measures have not 
been validated in other languages.
Multimorbidity is evenly distributed across age and 
sex.10 Thus, we expect to recruit males and females in a 
1:1 ratio, evenly distributed across ages. Our age range is 
broad to increase coverage and generalisability. We will 
include children and youth who, as a function of their 
physical condition, have a developmental or learning 
disability (eg, in certain presentations of epilepsy). For 
these children/youth, we will rely on parent reports only.
Procedures
Study procedures are outlined in figure 1. Participants 
will be recruited from the dermatology, endocrinology, 
gastroenterology, haemophilia, immunology, neurology, 
respirology and rheumatology programmes. Research 
assistants (RAs) will work in tandem with health profes-
sionals to help identify eligible families. Clinic nurses will 
introduce the study to families and invite them to speak 
with the RA either before or after their medical appoint-
ment. The RA will verify eligibility, describe the study and 
obtain written permission from eligible participants to be 
contacted a few days later.
The study coordinator will then contact parents to 
schedule a time for participants to complete the struc-
tured interviews and biological sample collections at 
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the hospital. Alternatively, the RA may meet with partici-
pants at their home to accommodate travel or child care 
schedules. In the rare case that a family is not able to 
meet in- person (either at the hospital or in their home), 
packages will be mailed, followed by telephone calls from 
the study coordinator with reminders for completion. 
During study visits at the hospital, the RA will meet with 
participants in a private research office. Informed written 
consent (parent and youth aged 16 years) and assent 
(children and youth aged 7–15 years) will be obtained at 
the beginning of the first visit.
Data collection for MY LIFE is based on the following 
a priori consideration that assessments should be far 
enough apart to allow sufficient time for detectable 
changes to occur in measures of children and youth, 
family and clinical characteristics and to not burden 
participants. Data will be collected every 6 months during 
the first year given that the period close to diagnosis is a 
dynamic time in terms of clinical management and family 
adaptation, and then again 1 year later. The experience 
of our research team suggests that a 2- year follow- up is 
adequate for detecting meaningful changes in psychoso-
cial outcomes of children and youth with physical condi-
tions.33 50 51 Data will be collected using independent 
structured interviews and self- reported questionnaires 
on a laptop (computer assisted to minimise missing data) 
for children/youth and parents to ensure privacy. Parent 
reports will be collected for all participating youth; youth 
aged ≥10 years will also provide reports. Data collection 
will take approximately 60–90 min. On completion of 
each interview, children/youth and parents will both be 
provided with a $30 gift card and if applicable, a parking 
voucher.
Measures
We will implement a multilevel, multimethod and multi- 
informant approach to data collection. Variables will 
be measured at the individual, family and community- 
levels using child/youth and parent- report and linkage 
with administrative health records obtained for the study 
period.
Self-reported measures
We will be using two measures of child and youth mental 
health as our primary outcome of interest. The Mini 
International Neuropsychiatric Interview for Children 
and Adolescents (MINI- KID) is a clinical diagnostic 
interview designed to assess the presence of Diagnostic 
and Statistical Manual of Mental Disorders (DSM)-5 and 
International Statistical Classification of Diseases and 
Related Health Problems (ICD)-10 psychiatric disor-
ders in children and youth over the past 6 months.52 We 
will be utilising the following modules which represent 
the most common mental disorders in childhood and 
adolescence53 54: major depressive episode, separation 
anxiety disorder, social anxiety disorder, specific phobia, 
attention- deficit hyperactivity disorder, conduct disorder, 
oppositional defiant disorder and generalised anxiety 
disorder. The MINI- KID has demonstrated strong validity 
and reliability in population and clinical samples of chil-
dren and youth.30 55
Second, the Ontario Child Health Study Emotional 
Behavioural Scales (OCHS- EBS) are a set of self- reported 
checklists measuring symptoms of psychopathology over 
the past 6 months using a 3- point Likert scale.55 56 Items 
are scored 0, 1, or 2, indicating responses of ‘never or not 
true’, ‘sometimes or somewhat true’ and ‘often or very 
true’, respectively. The raw scores are summed to calculate 
a scale score for each mental disorder (major depressive, 
generalised anxiety, separation anxiety, social phobia, 
attention- deficit hyperactivity, oppositional defiant, 
conduct), as well as total severity score and scores for 
internalising and externalising disorders. The OCHS- EBS 
demonstrates robust psychometric properties.55 56
Child/youth and parent mental health and quality of 
life, child/youth physical and psychosocial functioning, 
child/youth intelligence, family environment and 
sociodemographic characteristics will be assessed using 
psychometrically robust self- reported measures. When 
applicable, parents will also complete quality of life and 
mental health measures for a sibling within 3 years of age 
from the child in the study to understand the broader 
impact of child and youth multimorbidity on family 
members. Details of these measures are described in 
table 1.
biological assessments
To date, the few studies that have assessed markers of 
systemic inflammation suggest associations with child and 
youth mental health.57 58 We will measure whether system-
atic inflammatory biomarkers (which tend to be higher in 
young people with physical conditions)59–61 mediate the 
timing of onset of multimorbidity. We will collect dried 
blood spots for all children and youth and whole blood 
for youth ≥10 years at each measurement occasion. Our 
procedures for collecting dried blood spots by research 
staff have been adapted from published guidelines.62 
Whole blood samples will only be collected during study 
interviews in hospital by experienced phlebotomists. 
Samples will be analysed using high- sensitivity ELISA to 
quantify levels of C- reactive protein, tumour necrosis 
factor-α, interleukin-1β and interleukin-6, as these are 
robust indicators of systemic inflammation.62
Cortisol, a glucocorticoid hormone, is released by 
the hypothalamic- pituitary- adrenal axis in response to 
stress.63 Cortisol extracted from saliva, urine and blood 
provides transient measures of physiological stress, with 
limited utility for understanding chronic physiological 
stress in young people with chronic conditions.64 Hair 
cortisol concentration has recently been identified as a 
potentially valuable biomarker, averaging daily fluctu-
ations in circulating cortisol levels.65–68 Hair sampling 
represents a non- invasive method to measure chronic 
physiological stress and reduces the impact of individual 
and contextual differences associated with circulating 
cortisol.69 70 Hair will be collected using a standardised 
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Table 1 Study questionnaires
Construct Measure and description Informant
Child/youth mental health Ontario Child Health Study Emotional Behavioural Scales55 56
52- item symptom checklist providing total, internalising and externalising scores, as well as 
subscale scores for major depressive disorder, separation anxiety, social phobia, generalised 
anxiety, attention- deficit hyperactivity, oppositional defiant disorder and conduct disorder
Child/youth and 
parent
Strengths and Difficulties Questionnaire87
25- item checklist providing total difficulties scores, as well as domains of emotional problems, 
conduct problems, hyperactivity, peer problems and prosocial
Parent
Child/youth psychosocial 
health
KIDSCREEN88
27- item scale of health- related quality of life with domain scores for physical well- being, 
psychological well- being, autonomy and parent relations, peers and social support and school 
environment
Child/youth and 
parent
Self Description Questionnaire89 90
Five items from the General Self- image subscale; adapted from the National Longitudinal Survey 
of Children and Youth
Child/youth and 
parent
Self- Perception Profile for Children91 92
36- item scale assessing self- concept in the domains of scholastic competence, social 
acceptance, athletic competence, physical appearance, behavioural conduct and global self- 
worth
Child/youth
Child/youth physical health WHO Disability Assessment Schedule 2.093 94
12- item measure of disability and functioning in the domains of cognition, mobility, self- care, 
getting along, life activities and participation
Child/youth and 
parent
Child/youth intelligence Kaufman Brief Intelligence Test, second edition95
Brief measure of verbal and non- verbal intelligence
Child/youth
Parent mental health Center for Epidemiologic Studies Depression Scale96
20- item measure of depressive symptoms across four domains depressed affect, positive affect, 
somatic activity and interpersonal relations
Parent
Generalized Anxiety Disorder97
Seven items measuring symptoms of generalised anxiety
Parent
Parent quality of life Short Form-3698
36- item scale that assesses eight health domains: physical functioning, bodily pain, role 
limitations due to physical health problems, role limitations due to personal or emotional 
problems, emotional well- being, social functioning, energy/fatigue and general health 
perceptions, and a single item that provides an indication of perceived change in health
Parent
Family environment McMaster Family Assessment Device99 100
12 items comprising the General Functioning subscale measures aspects of communication, 
problem solving, behavioural control, affective responsiveness and involvement and roles
Parent
Parental Stress Scale101 102
18- item scale that includes four domains of parenting: rewards, stressors, loss of control and 
satisfaction
Parent
Sibling Inventory of Differential Experience103
18- item scale assessing differential treatment by mother and father in relation to closest- aged 
sibling
Child/youth
School environment and 
peers
2014 Ontario Child Health Study (OCHS)104
14 items assessing school climate, bullying and participation in extra- curricular activities
Child/youth
Mental healthcare Various items obtained from the OCHS and Canadian Community Health Survey Parent
Sociodemographics Various items obtained from population- based surveys conducted by Statistics Canada Parent
Only youth ≥10 provided self- reported data.
approach by research staff from children/youth and 
parents by cutting approximately 80 strands (roughly 
4 mm diameter) from the posterior vertex of the head, as 
close to the scalp as possible. the extraction and assaying 
of cortisol will follow established procedures, which we 
have also used previously.34 Variables hypothesised to 
affect hair cortisol concentration (eg, hair washes, medi-
cations, smoking behaviour (including exposure to 
secondhand smoke)) will be collected via parent report 
on a separate form.67 71 72
While parents are completing study questionnaires, chil-
dren 2–5 years will complete the Peabody Developmental 
Motor Scales, second edition (PDMS-2) to assess gross motor 
development.73 This measure, which requires 20–30 min 
to complete, is collected only at study visits conducted at 
the hospital. We will be using three gross motor subtests—
stationary, locomotion and object manipulation—to obtain 
a gross motor developmental quotient. The PDMS-2 has 
excellent reliability and is valid for evaluating children/
youth with varying levels of gross motor skills.74
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Habitual physical activity at each assessment will be 
monitored using accelerometery, providing the duration, 
intensity and frequency of movement among children 
and youth. Following standard practice, we will monitor 
physical activity over seven consecutive days, reflecting 
recent levels of physical activity.75 76 Activity intensity is 
analysed according to cut- points developed and validated 
specifically for this unit (ActiGraph wGT3X- BT).77 Sitting 
and standing height and weight will also be collected for 
children and youth at each assessment.
Patient and public involvement
Patients or the public were not involved in the design, or 
conduct, or reporting of this protocol. The role of partic-
ipating families with regards to our knowledge translation 
strategy is described in the Ethics and dissemination section.
dAtA AnAlySIS And lInkAgE
Sample size calculation
Simulations that altered various parameter estimates were 
conducted to determine the sample size requirements for 
this study.78 79 Results suggested that a study with 250 chil-
dren and youth and four measurement occasions would 
be adequately powered (1−β≥0.80) at α=0.05 to estimate 
non- linear changes in mental health trajectories (primary 
study objective), examine relevant mediating and moder-
ating effects and explore subgroup differences (eg, by phys-
ical health or mental disorder). Assuming 40% of eligible 
children/youth or their parents refuse participation after 
being provided with details of the study, and 20% of initially 
enrolled children/youth do not complete the baseline 
assessment, we anticipate approaching approximately 520 
families about the study. If appropriate, multiple imputa-
tion will be used to account for missing data.
data analysis
Multilevel models will delineate trajectories of psychopa-
thology and psychosocial outcomes over time, survival anal-
ysis and proportional hazard models will be used to model 
risk and predictors of child and youth multimorbidity, and 
structural equation modelling will identify factors that 
mediate and moderate outcomes.80 81 Multinomial logistic 
regression will be used to model patterns of mental health 
service use for children and youth with and without multi-
morbidity. Additional analyses will be stratified to examine 
subgroup differences, including by sex, because prevalence 
of and pathways to mental disorder is not the same for males 
and females.53 82 83 When possible, we will use age- stratified 
analysis based on developmental periods to address the 
challenge of making inferences on heterogeneous samples. 
The developmental periods will be early childhood (2–6 
years), middle childhood/early adolescence (7–12 years) 
and older adolescence (13–16 years).
data linkage
Study data will be linked using the provincial health 
numbers of participants with the health data collected by 
the Ministry of Health to obtain information on mental 
health service use. Databases to be linked will include the 
National Ambulatory Care Reporting System, Discharge 
Abstract Database and Ontario Health Insurance Plan. 
We will use postal codes to link study data with Canadian 
census data to measure community- level variables, such 
as neighbourhood income and geographic proximity to 
health services.
dISCuSSIon
Child and youth multimorbidity creates considerable 
challenges for the individual, family and healthcare 
system. By focusing on modifiable predictors and asso-
ciated health and psychosocial outcomes of child and 
youth multimorbidity, this study will advance knowledge 
of the aetiology and course of mental disorder in a large 
vulnerable population and refine our understanding of 
how child and youth multimorbidity influences interac-
tion with the healthcare system.
We note the following challenges associated with 
conducting this study. First, the eligibility criteria are 
purposefully broad—in terms of age and physical health 
problems—in order to enrol a large enough sample of 
children and youth to address our objectives. This hetero-
geneity may limit the applicability of findings to specific 
subgroups (eg, young children, youth with juvenile 
arthritis). However, evidence suggests that differences 
in risk for mental disorder across physical conditions 
is negligible.8 11 24 26 In addition, we will conduct age 
and condition- stratified analyses to adjust for potential 
residual confounding and identify potential stratum- 
specific findings.
Second, attrition may be problematic. Because our 
study includes parents and children/youth, attrition of 
one member of the dyad may likely result in the other 
being lost. To mitigate and minimise sample loss, we are 
oversampling, implementing a strong follow- up strategy 
which include multiple contacts over time,84 and using 
robust statistical methods to compute unbiased estimates 
in the presence of missing data.84–86
Third, at the time of this proposal, some mental health 
services were funded by the provincial Ministry of Chil-
dren, Community and Social Services (MCCSS). These 
services are not captured in the datasets in which we 
will link our study data. Our previous experience has 
shown that linkage with MCCSS is not possible; we will 
overcome this challenge by directly asking parents about 
the MCCSS- funded mental health services they access 
using the methods described in population- based studies 
conducted by Statistics Canada.
In summary, we expect that findings from MY LIFE will 
lead to development and implementation of universal 
and targeted risk- reduction strategies to reduce mental 
disorder in children and youth with physical conditions 
and will inform initiatives for the integration of physical 
and mental healthcare for children and youth—poten-
tially aiding in eliminating stigma surrounding mental 
health and help- seeking. Ultimately, findings from this 
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study will improve the quality of life for children and 
youth and their families, and potentially reduce burdens 
on the healthcare system.
EthICS And dISSEMInAtIon
MY LIFE received ethical approval from the University of 
Waterloo Human Research Ethics Board (ORE-22183) 
and the Hamilton Integrated Research Ethics Board 
(2797). Dissemination of findings will target academic 
outlets including publication in peer- reviewed journals 
and presentations at national and international confer-
ences. We will engage health professional and adminis-
trative stakeholders with presentations at departmental 
rounds and divisional meetings to discuss opportunities 
to improve child and youth health through clinical prac-
tice changes informed by findings from MY LIFE.
At the end of the study, participating families will 
receive a report detailing findings in a coherent, under-
standable format. Additionally, we will partner with fami-
lies to co- produce pamphlets containing key messages 
from this study; what to expect postdiagnosis of a physical 
condition, supportive services for children and youth and 
families, and information about the signs and symptoms 
of mental disorder. Pamphlets will be distributed to clinics 
and community agencies, as well as websites known for 
their reach and impact (eg, Mental Health Commission 
of Canada, Centre for Addiction and Mental Health).
We will also disseminate findings to the mental health 
community. The principal investigator will give webinars 
to staff of mental health agencies and their clients which 
will be recorded and distributed using existing knowl-
edge translation infrastructure. Finally, we will incorpo-
rate social media into our dissemination strategy to reach 
the general community through media releases, summa-
ries on institution websites, and communicate findings via 
popular outlets (eg, Twitter).
twitter Mark A Ferro @ARCH_Lab and Jan Willem Gorter @Dr_Gorter
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